VarmX B.V.

Quick facts

Phase 3 pipeline

• UFH · Cardiovascular
  UFH acts as an anticoagulant by inhibiting the coagulation cascade, specifically by inactivating Factor Xa and thrombin.
• Usual Pharmacological Care · Cardiovascular
  Usual Pharmacological Care involves the standard treatment approach for a medical condition.
• VMX-C001 · Diabetes
  VMX-C001 is a small molecule that targets the SGLT2 receptor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• VarmX B.V. portfolio CI brief
• VarmX B.V. pipeline updates RSS